The most common side effects of topical minoxidil are scalp itching and irritation, a temporary shed in the first weeks, and unwanted facial hair, which was more frequent with 5% than with 2% in trials. Serious effects are rare with topical use, and most people tolerate it well. Gains fade if you stop, which is why many people look at non-drug options: red-light devices, microneedling and rosemary oil each have randomized trials, used alone or alongside minoxidil.
Key takeaways
- Topical minoxidil beat placebo in 48-week trials of 393 men and 381 women with pattern hair loss.
- Scalp irritation is often caused by propylene glycol in the solution; the 5% foam is propylene-glycol-free.
- In women, 5% solution caused more itching, irritation and unwanted facial hair than 2% (Lucky 2004).
- If you stop minoxidil, the extra hair it was supporting sheds over the following months; you return to where you would have been, not worse.
- Non-drug options with randomized trials: red-light devices (more hair than sham at 16–26 weeks), rosemary oil (comparable to 2% minoxidil at 6 months) and microneedling (added to minoxidil in trials).
What is minoxidil and how well does it work?
Minoxidil is the best-tested over-the-counter drug for pattern hair loss in men and women. It keeps follicles in anagen, the growth phase, so thin hairs can grow thicker and longer.
It began in the 1970s as a blood-pressure pill whose users grew extra hair. The topical version has been sold for hair loss since the late 1980s as a 2% or 5% solution, or a 5% foam. It opens potassium channels and widens small blood vessels, and it needs a scalp enzyme (a sulfotransferase) to become active, which helps explain why some people respond more than others.
Three placebo-controlled trials are worth knowing:
- Olsen et al. 2002: 393 men aged 18 to 49, 48 weeks, 5% versus 2% versus placebo. Both strengths beat placebo on hair counts, and 5% beat 2%.
- Lucky et al. 2004: 381 women aged 18 to 49, 48 weeks, same three arms. Both strengths beat placebo on hair counts; 5% scored higher on patient-rated benefit but caused more itching, irritation and facial hair.
- Olsen et al. 2007: 352 men, 16 weeks, propylene-glycol-free 5% foam versus placebo foam. The foam increased hair counts.
For women, once-daily 5% foam and twice-daily 2% solution produced similar gains at 24 weeks, 23.9 and 24.2 more hairs per cm², though the trial narrowly missed its formal noninferiority margin (Blume-Peytavi et al., 2016). These trials enrolled adults under 50 and ran for up to a year. For the women's side of the picture in more depth, see our guide to androgenetic alopecia in women.
| Formulation | 2% solution | 5% solution | 5% foam |
|---|---|---|---|
| Typical use | Twice daily | Twice daily for men; women should follow their doctor's advice | Once daily for women, twice daily for men |
| Propylene glycol | Yes | Yes | No |
| Itching and irritation | Lower | Higher than 2% in trials | Often easier on sensitive scalps |
| Facial hair in women | Lower | Higher than 2% in trials | Follow label dosing |
| Key trial | Men and women, 48 weeks | Largest effect in men at 48 weeks | Similar gains to 2% solution in women at 24 weeks |
What are the side effects of minoxidil?
Most side effects are local and mild: itching, flaking, an early shed and facial hair. Body-wide effects are rare with topical use.
- Scalp irritation. Itching, dryness, flaking and redness are the most common complaints. Much of it is contact irritation from propylene glycol in the solution, and switching to the foam often helps.
- Early shedding. In the first weeks, often within the first two months, minoxidil pushes resting hairs out so new growth can start. It can look like things are getting worse; it usually settles. Stopping at this point is the most common way people miss out on the benefit.
- Unwanted facial hair. Fine hair on the forehead, temples or cheeks was more frequent with 5% than 2% in the Lucky trial. It can be related to product spreading to the face from hands or a pillow, so dose and careful application matter: use the measured amount, let it dry before bed and wash your hands afterward. It usually fades after reducing or stopping.
- Headache, dizziness, palpitations, low blood pressure, ankle swelling. Rare with topical use because little is absorbed, but reported, and more likely if you use more than directed or apply it to broken skin.
Minoxidil side effects in women
Women get the same side effects as men, but unwanted facial hair (hypertrichosis) is often the one that matters most, and it depends on strength. In the 48-week Lucky trial of 381 women aged 18 to 49, both 2% and 5% solution beat placebo on hair counts, and 5% scored higher on patient-rated benefit, but it also caused more itching, irritation and facial hair than 2% (Lucky et al., 2004). It usually shows up as fine hair on the forehead, temples or cheeks and tends to fade after reducing or stopping. If facial hair or itching is a concern, ask your doctor or pharmacist about the 2% solution or the once-daily 5% foam, which gave similar gains to twice-daily 2% solution at 24 weeks and contains no propylene glycol.
Is oral minoxidil different?
Yes. Low-dose oral minoxidil is a prescription medicine used off-label for pattern hair loss, and it acts on the whole body. It avoids scalp irritation, but body-wide hair growth, fluid retention, a faster heart rate and low blood pressure are recognized side effects. It needs a prescriber who monitors you; it is not something to source online.
Do you become dependent on minoxidil?
Not in the drug-dependence sense: there is no withdrawal and no tolerance. But it works only while you use it.
Pattern hair loss is driven by follicle sensitivity to DHT, and that process continues underneath. Minoxidil holds follicles in the growth phase while it is on the scalp. Stop, and within a few months the hairs it was supporting shed and density drifts back to where it would have been. You lose the gain, not more. Decide up front whether daily use for years suits you, and never stop a prescribed course without talking to the prescriber.
Which non-drug alternatives to minoxidil have evidence?
Three non-drug options have randomized trials: red-light devices, rosemary oil and microneedling. Light and rosemary were tested on their own; microneedling was tested as an add-on to minoxidil.
| Option | Key trial | Who | What it found |
|---|---|---|---|
| Red-light devices (low-level light therapy) | Jimenez et al. 2014 | 128 men, 141 women; 655 nm laser comb, 3 times a week, 26 weeks | Device users gained 18–26 terminal hairs per cm², against about 2–9 with sham |
| Red-light devices (helmet) | Lanzafame et al. 2014 | 47 women; 655 nm lasers and LEDs, every other day, 16 weeks | Hair counts rose by about 100 in the measured area, against about 24 with sham |
| Rosemary oil | Panahi et al. 2015 | 100 people with pattern hair loss, 6 months | Hair counts rose in both the rosemary and 2% minoxidil groups, with no significant difference; less scalp itching with rosemary |
| Microneedling (with minoxidil) | Dhurat et al. 2013 | 100 men; weekly 1.5 mm clinic microneedling plus 5% minoxidil, 12 weeks | Average gain of 91.4 hairs in a 1 cm² target area with microneedling plus minoxidil, against 22.2 with minoxidil alone |
Red light therapy
Red-light devices have the largest body of sham-controlled evidence among non-drug options, in men and women, with combs and helmet-style devices. Hair trials mostly used red light around 630 to 680 nm and measured results at 16 to 26 weeks; some devices also add near-infrared light (about 850 nm). Our guide to light therapy wavelength and dose explains how to compare devices, and does red light therapy work for hair loss goes through every trial.
If you want a drug-free step that is easy to keep up, the Folliq Red Light Scalp Massager combines 24 red LEDs at 660 nm with soft, sonic-vibration silicone bristles in a 6-minute session, 3 to 5 times a week. It is shower-safe, holds about 14 sessions per charge and comes with 90 days to try it.
Rosemary oil
Rosemary oil has one randomized trial, in which it was comparable to 2% minoxidil at 6 months. Neither group changed at 3 months, both increased hair counts by 6 months, and scalp itching was less frequent with rosemary. Our review of the rosemary oil research walks through the trial in detail.
Microneedling
Microneedling's trials pair it with minoxidil, so it fits best as an add-on for people already using minoxidil. The Dhurat trial used a 1.5 mm roller weekly in a clinic; home rollers are shorter, typically 0.5 mm, used 2 to 3 times a week and never on consecutive days. Our guide to whether microneedling helps thinning hair covers the evidence, and derma rolling needle size, frequency and safety covers the practical rules.
For a direct comparison of the two most popular options on commitment, side effects and cost, see red light therapy vs minoxidil.
Can you combine minoxidil with these options?
Often, yes, but tell your doctor or pharmacist first. Each pairing has its own rule.
- Red light. A 2025 meta-analysis of 7 randomized trials found a greater increase in hair density and thickness with low-level laser therapy plus minoxidil than with minoxidil alone, and no difference in side effects (Mawu et al., 2025). Use the device on a clean, dry scalp, then apply minoxidil.
- Microneedling. Needling increases how much of a topical gets through the skin. In the Dhurat protocol, patients skipped minoxidil on needling day and restarted 24 hours later.
- Rosemary oil. On a scalp already irritated by minoxidil, adding another leave-on can add to the irritation. Introduce one product at a time.
- Prescription medicines. If you take oral minoxidil, spironolactone or any blood-pressure medicine, combining treatments is a question for your prescriber. Don't reduce or stop a prescribed drug on your own.
When should you see a doctor?
See a doctor before starting minoxidil if you have heart disease or low blood pressure, or are pregnant or breastfeeding. Stop and get medical advice if you have chest pain, palpitations, dizziness, sudden weight gain or swollen ankles. See a dermatologist rather than self-treating if hair loss came on suddenly, is patchy, or comes with an itchy, scaly or painful scalp; those signs point to other causes, such as telogen effluvium, alopecia areata or an inflammatory scalp condition.
FAQ
How long do minoxidil side effects last?
Early shedding usually settles within the first couple of months as new growth takes over. Scalp irritation often improves after switching from solution to foam. If side effects persist or affect your heart rate or blood pressure, stop and see a doctor.
Does minoxidil cause facial hair in women?
It can. In the 381-woman Lucky trial, unwanted facial hair was more common with 5% solution than with 2%. Applying the measured dose, letting it dry before bed and washing your hands afterward reduces the chance of spreading it to your face.
What is the best natural alternative to minoxidil?
Red-light devices have the most sham-controlled trials of the non-drug options, in both men and women. Rosemary oil has one randomized trial comparing it with 2% minoxidil. Many people combine a light device with a rosemary-based topical as a drug-free routine.
Can I switch from minoxidil to a natural alternative?
You can, but expect the extra hair minoxidil was supporting to shed over the following months. Some people start the new routine a few months before stopping minoxidil so the two overlap. Talk to your doctor before changing a prescribed treatment.
Is minoxidil safe to use long term?
Topical minoxidil has been used for decades, and the major trials found it well tolerated without systemic effects at the recommended doses. Long-term use is the norm, because the benefit lasts only while you keep using it.
Folliq products are cosmetic scalp-care products, not medical devices or medicines, and are not intended to diagnose, treat, cure or prevent any disease. The studies discussed here used clinical devices and preparations, which is why every Folliq product comes with 90 days to try it for yourself. If your hair loss is sudden, patchy or painful, see a dermatologist.
References
- Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology. 2002. PMID 12196747
- Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. Journal of the American Academy of Dermatology. 2004. PMID 15034503
- Olsen EA, Whiting D, Bergfeld W, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology. 2007. PMID 17761356
- Blume-Peytavi U, Shapiro J, Messenger AG, et al. Efficacy and safety of once-daily minoxidil foam 5% versus twice-daily minoxidil solution 2% in female pattern hair loss: a phase III, randomized, investigator-blinded study. Journal of Drugs in Dermatology. 2016. PMID 27391640
- Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. American Journal of Clinical Dermatology. 2014. PMID 24474647
- Lanzafame RJ, Blanche RR, Chiacchierini RP, Kazmirek ER, Sklar JA. The growth of human scalp hair in females using visible red light laser and LED sources. Lasers in Surgery and Medicine. 2014. PMID 25124964
- Panahi Y, Taghizadeh M, Marzony ET, Sahebkar A. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. Skinmed. 2015. PMID 25842469
- Dhurat R, Sukesh M, Avhad G, Dandale A, Pal A, Pund P. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. International Journal of Trichology. 2013. PMID 23960389
- Mawu FO, Sondakh ORL, Kairupan TS, Christopher PM. Comparative efficacy and safety of low-level laser therapy and topical minoxidil combination vs. topical minoxidil monotherapy in androgenetic alopecia management: a systematic review and meta-analysis of randomized controlled trials. Lasers in Medical Science. 2025. PMID 40826200